HBV Mutation Detail Information

> S202I Search Result


Mutation Information
Mutation Site S202I
Mutation Type Amino acid level
Gene/Protein/Region Type RT
Genotype/Subtype D
Relevant Drug lamivudine (LAM)
Country Ethiopia
Literature Information
PubMed PMID 33211768
Disease Occult HBV infection
Published Year 2020
Journal PloS one
Title Prevalence and genetic variability of occult hepatitis B virus in a human immunodeficiency virus positive patient cohort in Gondar, Ethiopia.
Author Patel NH,Meier-Stephenson V,Genetu M,Damtie D,Abate E,Alemu S,Aleka Y,Van Marle G,Fonseca K,Coffin CS,Deressa T
Evidence Further, anti-HBV drug resistant mutations (rtI169T, rtV173L, rtA181T, rtT184A/C/G, rtA194T, rtS202I, M204I, rtM250L/V) were detected in 5/22 (23%) patients.

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation